During epithelial-mesenchymal transition (EMT), a process central to cancer metastasis, tumor cells frequently downregulate or lose EpCAM expression, further reducing the method’s effectiveness in identifying specific CTC subsets (42). The gene discussed is EPCAM; the disease is cancer.